Clinical Trial: Research on the Application of Multimodal Machine Learning Models Based on MASP1 and NCAN in Early Screening and Prognostic Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) (China)

China, Aug. 21 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Research on the Application of Multimodal Machine Learning Models Based on MASP1 and NCAN in Early Screening and Prognostic Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130457

Registration Time: 2026/08/20

Type: Observational study

Primary Sponsor: Shanghai Minhang District centeral hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333871

Published by HT Digital Content Services with permission from Health Daily Digest....